Dose-Adjusted EPOCH Regimen as First-Line Treatment for Non-Hodgkin's Lymphoma with Hemophagocytic Lymphohistiocytosis: A Single-Arm, Open-Label, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3304299 ◽

2018 ◽

Author(s):

Jin-Hua Liang ◽

Li Wang ◽

Hua-Yuan Zhu ◽

Jun Qian ◽

Hui Liao ◽

...

Keyword(s):

Hemophagocytic Lymphohistiocytosis ◽

Hodgkin's Lymphoma ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Non Hodgkin's Lymphoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(14)70461-9 ◽

2014 ◽

Vol 15 (13) ◽

pp. 1433-1441 ◽

Cited By ~ 72

Author(s):

Pasi A Jänne ◽

Sai-Hong I Ou ◽

Dong-Wan Kim ◽

Geoffrey R Oxnard ◽

Renato Martins ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Abstract C122: A randomized, multicenter, open-label, phase 2 study of paclitaxel-carboplatin (PC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus PC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC)

10.1158/1535-7163.targ-15-c122 ◽

2015 ◽

Author(s):

David Spigel ◽

Alexander Luft ◽

Rodryg Ramlau ◽

Mazen Khalil ◽

Joo-Hang Kim ◽

...

Keyword(s):

Stage Iv ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

European Journal of Cancer ◽

10.1016/j.ejca.2014.10.008 ◽

2014 ◽

Vol 50 (18) ◽

pp. 3077-3088 ◽

Cited By ~ 16

Author(s):

S.W. Lam ◽

S.M. de Groot ◽

A.H. Honkoop ◽

A. Jager ◽

A.J. ten Tije ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Locally Recurrent ◽

First Line Treatment

Download Full-text

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial

Haematologica ◽

10.3324/haematol.2019.220301 ◽

2019 ◽

Vol 105 (1) ◽

pp. e29-e32 ◽

Cited By ~ 2

Author(s):

Jin-Hua Liang ◽

Li Wang ◽

Hua-Yuan Zhu ◽

Jun Qian ◽

Hui Liao ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Phase Ii ◽

Hemophagocytic Lymphohistiocytosis ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Non Hodgkin Lymphoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

TIGER 1: A randomized, open-label, phase 2/3 study of rociletinib (CO-1686) or erlotinib as first-line treatment for EGFR-mutant non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps8108 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS8108-TPS8108 ◽

Cited By ~ 1

Author(s):

D. Ross Camidge ◽

Juergen Wolf ◽

Jason B. Litten ◽

Linda A Higashi ◽

Jeffrey D. Isaacson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

The Lancet Haematology ◽

10.1016/s2352-3026(18)30131-5 ◽

2018 ◽

Vol 5 (9) ◽

pp. e403-e410 ◽

Cited By ~ 9

Author(s):

Hervé Tilly ◽

Franck Morschhauser ◽

Olivier Casasnovas ◽

Thierry Jo Molina ◽

Pierre Feugier ◽

...

Keyword(s):

Follicular Lymphoma ◽

Line Treatment ◽

Phase 2 ◽

Tumour Burden ◽

First Line ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Dacomitinib as first-line treatment of locally-advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): Interim analysis of an open-label, single-group, phase 2 trial

Annals of Oncology ◽

10.1093/annonc/mdw373.67 ◽

2016 ◽

Vol 27 ◽

pp. vi292

Author(s):

A. Necchi ◽

D. Giardiello ◽

D. Raggi ◽

P. Giannatempo ◽

N. Nicolai ◽

...

Keyword(s):

Interim Analysis ◽

Locally Advanced ◽

Line Treatment ◽

Phase 2 ◽

Single Group ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Penile Squamous Cell Carcinoma ◽

First Line Treatment

Download Full-text

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial

The Lancet Haematology ◽

10.1016/s2352-3026(18)30054-1 ◽

2018 ◽

Vol 5 (6) ◽

pp. e261-e269 ◽

Cited By ~ 9

Author(s):

Qiu-Dan Shen ◽

Hua-Yuan Zhu ◽

Li Wang ◽

Lei Fan ◽

Jin-Hua Liang ◽

...

Keyword(s):

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Large B Cell Lymphoma ◽

Open Label Phase ◽

Large B Cell ◽

First Line Treatment

Download Full-text

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(20)30755-5 ◽

2021 ◽

Vol 22 (4) ◽

pp. 463-475

Author(s):

Joël Guigay ◽

Anne Aupérin ◽

Jérôme Fayette ◽

Esma Saada-Bouzid ◽

Cédrik Lafond ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

First Line Treatment

Download Full-text

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

European Urology ◽

10.1016/j.eururo.2014.11.003 ◽

2015 ◽

Vol 67 (4) ◽

pp. 599-602 ◽

Cited By ~ 23

Author(s):

Thomas Geldart ◽

John Chester ◽

Angela Casbard ◽

Simon Crabb ◽

Tony Elliott ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Advanced Urothelial Carcinoma ◽

First Line Treatment ◽

Gemcitabine And Cisplatin

Download Full-text